BridgeBio Oncology Therapeutics, Inc.
BBOT
$6.76
-$2.11-23.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.53% | -40.71% | -9.15% | 256.39% | -3.18% |
| Total Receivables | 352.74% | -62.18% | 70.80% | -79.02% | 2,592.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.67% | 114.98% | -12.66% | 74.56% | 60.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 92.24% |
| Total Current Assets | -9.05% | -38.37% | -9.16% | 234.40% | 0.72% |
|
|
|||||
| Total Current Assets | -9.05% | -38.37% | -9.16% | 234.40% | 0.72% |
| Net Property, Plant & Equipment | -5.51% | -3.96% | 0.58% | -5.28% | 2.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.68% | -10.46% | 130.22% | 1.06% | 6.00% |
| Total Assets | -9.80% | -6.85% | -7.51% | 220.52% | 0.95% |
|
|
|||||
| Total Accounts Payable | -44.35% | 779.91% | -62.36% | 66.14% | -39.86% |
| Total Accrued Expenses | 44.96% | -8.26% | 5.66% | 26.48% | 51.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.97% | 3.07% | 3.16% | 58.13% | 5,233.33% |
| Total Finance Division Other Current Liabilities | 37.71% | 34.08% | -22.72% | 109.39% | -92.36% |
| Total Other Current Liabilities | 37.71% | 34.08% | -22.72% | 109.39% | -92.36% |
| Total Current Liabilities | 19.36% | 23.46% | -1.88% | 31.05% | 13.28% |
|
|
|||||
| Total Current Liabilities | 19.36% | 23.46% | -1.88% | 31.05% | 13.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.93% | -6.15% | -5.75% | -5.29% | -4.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.14% | 21.67% | -2.12% | 27.98% | 11.48% |
|
|
|||||
| Common Stock & APIC | 0.94% | 0.56% | 0.42% | 1,590.14% | 1.97% |
| Retained Earnings | -14.16% | -11.81% | -12.21% | -16.39% | -11.63% |
| Treasury Stock & Other | 2.24% | -6,231.25% | -55.56% | -29.41% | -73.30% |
| Total Common Equity | -13.21% | -9.44% | -7.97% | 296.15% | -13.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 8.06% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 8.06% |
|
|
|||||
| Total Common Equity | -13.21% | -9.44% | -7.97% | 296.15% | -13.85% |
| Total Preferred Equity | -- | -- | -- | -- | 8.06% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.21% | -9.44% | -7.97% | 267.69% | -1.34% |
|
|
|||||